<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51855">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01782430</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0141</org_study_id>
    <secondary_id>2012-A00778-35</secondary_id>
    <nct_id>NCT01782430</nct_id>
  </id_info>
  <brief_title>PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation</brief_title>
  <acronym>PREONIV</acronym>
  <official_title>PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ICU, University Hospital Gabriel-Montpied, CHU Clermont-FD, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized clinical multicentric study, in ICU, during preoxygenation for the
      intubation of hypoxemic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective randomized clinical multicentric study in ICU, comparing standard oxygenation,
      high flow nasal oxygen therapy and non invasive ventilation (NIV) , with pulse oxymetry
      values (SpO2), during preoxygenation for hypoxemic patients
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>least  pulse oxymetry value</measure>
    <time_frame>at day 1</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulse oxymetry value (at the end of preoxygenation)</measure>
    <time_frame>at 5 minutes and at 30 minutes after intubation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial pressure of arterial oxygen (PaO2)</measure>
    <time_frame>at day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regurgitation rate</measure>
    <time_frame>at day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxyhemoglobin desaturation below 80 %</measure>
    <time_frame>at day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Adult Patients</condition>
  <condition>Requiring Intubation</condition>
  <condition>Hypoxemia (Defined by PaO2/FiO2( Fraction of Inspired Oxygen) Below 200)</condition>
  <condition>Patient Covered by French Health Care System</condition>
  <arm_group>
    <arm_group_label>Standard oxygenation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prospective randomized clinical multicentric study in ICU, comparing standard oxygenation, high flow nasal oxygen therapy and non invasive ventilation (NIV) , with pulse oxymetry values (SpO2), during preoxygenation for hypoxemic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal oxygen therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prospective randomized clinical multicentric study in ICU, comparing standard oxygenation, high flow nasal oxygen therapy and non invasive ventilation (NIV) , with pulse oxymetry values (SpO2), during preoxygenation for hypoxemic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>invasive ventilation (VNI)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prospective randomized clinical multicentric study in ICU, comparing standard oxygenation, high flow nasal oxygen therapy and non invasive ventilation (NIV) , with pulse oxymetry values (SpO2), during preoxygenation for hypoxemic patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>- standard oxygenation</intervention_name>
    <arm_group_label>Standard oxygenation</arm_group_label>
    <arm_group_label>High flow nasal oxygen therapy</arm_group_label>
    <arm_group_label>invasive ventilation (VNI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults patients

          -  requiring intubation and hypoxemia (defined by PaO2/FiO2 below 200)

          -  patient covered by french health care system

        Exclusion Criteria:

          -  patient refusal

          -  intubation for other causes (excluding hypoxemia)

          -  impossibility to measure pulse oxymetry value

          -  contraindication for NIV : vomiting

          -  NIV intolerance

          -  cardiac arrest during intubation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SÃ©bastien PERBET</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 31, 2013</lastchanged_date>
  <firstreceived_date>January 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preoxygenation</keyword>
  <keyword>Intubation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
